RxDoctor Payments Data

Rafael Garcia, MD

Family Medicine · Orange Park, FLNPI 1801068135

Payments from drug & device makers

$618in general payments, 2019–2025

Across 27 payments — averaging $22.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$256
  • Lundbeck LLC$180
  • AbbVie$55
  • Heartflow, Inc.$45
  • Therapeuticsmd, Inc.$25
  • AstraZeneca$24
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$618100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$618 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$28,245
Medicare patients
37
Services billed
295

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin36$58,262
EliquisApixaban90$40,228
JanumetSitagliptin Phos/Metformin Hcl17$22,266
LinzessLinaclotide13$16,011
EntrestoSacubitril/Valsartan25$14,398
XareltoRivaroxaban28$10,708
BrilintaTicagrelor28$6,935
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$4,270
Paliperidone ErPaliperidone13$3,645
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog25$2,781
Atorvastatin Calcium278$2,425
Wixela InhubFluticasone Propion/Salmeterol13$1,803
Levetiracetam47$1,209
Losartan Potassium129$1,193
Tamsulosin Hcl75$1,174

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$55$16,01113 claims
AstraZenecaBrilinta$24$6,93528 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Orange Park

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →